Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)-Reference-Cited by-同舟云学术

Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)

Published:2015-08-05 Issue:8 Volume:10 Page:e0134882
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Siqueira Raoni Pais,Barbosa Éverton de Almeida Alves,Polêto Marcelo Depólo,Righetto Germanna Lima,Seraphim Thiago Vargas,Salgado Rafael Locatelli,Ferreira Joana Gasperazzo,Barros Marcus Vinícius de Andrade,de Oliveira Leandro Licursi,Laranjeira Angelo Brunelli Albertoni,Almeida Márcia Rogéria,Júnior Abelardo Silva,Fietto Juliana Lopes Rangel,Kobarg Jörg,de Oliveira Eduardo Basílio,Teixeira Robson Ricardo,Borges Júlio César,Yunes Jose Andrés,Bressan Gustavo Costa

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. Alternative isoform regulation in human tissue transcriptomes;ET Wang;Nature,2008

2. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing;O Fedorov;Chem Biol,2011

3. VEGF-A splicing: the key to anti-angiogenic therapeutics?;SJ Harper;Nat Rev Cancer,2008

4. The pathobiology of splicing;AJ Ward;J Pathol,2010

5. Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA;CF Bourgeois;Prog Nucleic Acid Res Mol Biol,2004

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into multidrug resistance mechanisms: Exploring distinct miRNAs as prospective therapeutic agents in triple negative breast cancer;Gene Reports;2024-12

2. NMR analysis, cytotoxic activity and theoretical study of a complex between SRPIN340 and p -sulfonic acid calix[6]arene;Future Medicinal Chemistry;2024-07

3. Small molecules modulating RNA splicing: a review of targets and future perspectives;RSC Medicinal Chemistry;2024

4. New Insights Into Pyridoxal Kinase Inhibitors and Their Antileukemic Effects;Cureus;2023-11-02

5. Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis;Cell Reports;2023-11